Unum Therapeutics (UMRX, $3.32) was one of top quarterly gainers, jumping +850.2% to $3.32 per share. Tickeron A.I.dvisor analyzed 382 stocks in the Biotechnology Industry over the last three months, and discovered that 327 of them (85.6%) charted an Uptrend while 55 of them (14.4%) trended down. Tickeron A.I.dvisor found 51 similar cases when UMRX's price went up 15% within three months. In 51 out of those 51 cases, UMRX's price went down during the following month. Based on these historical data, Tickeron A.I. thinks the odds of an Uptrend reversal for UMRX are 90%.
The higher Bollinger Band was broken -- a price fall is expected as the ticker heads toward the middle band, which invites the trader to consider selling or shorting the ticker, or exploring put options. Tickeron AI shows that in 12 of 13 cases where UMRX's price broke its higher Bollinger Band, its price dropped further during the following month. The odds of a continued Downtrend are 90%.
The higher Bollinger Band was broken -- a price fall is expected as the ticker heads toward the middle band, which invites the trader to consider selling or shorting the ticker, or exploring put options. Tickeron AI shows that in 12 of 13 cases where UMRX's price broke its higher Bollinger Band, its price dropped further during the following month. The odds of a continued Downtrend are 90%.